Ibuprofen gels not a patch on new delivery tech say UK developers

By Gareth Macdonald contact

- Last updated on GMT

Medherant develops new delivery patch tech for pain drug delivery
Medherant develops new delivery patch tech for pain drug delivery

Related tags: Pharmacology

UK researchers have developed an ibuprofen patch they claim offers better dosage control than gel formulations of the pain drug.

The patch – which was developed by researchers at the University of Warwick and spinout company Medherant – consists of a transparent layer that is stuck to the skin with an adhesive polymer into which the active pharmaceutical ingredient (API) - in this case ibuprofen - is incorporated.

Medherant CEO Nigel Davis told us the approach enables precise dosage control because the patches have “a defined size with a set amount of drug.​”

He contrasted this with topical ibuprofen formulations that allow “patients to spread imprecise volumes of gel over different surface areas​.”

Higher drug loads

The matrix technology – which is owned Medherant – is capable holding a significant amount of API – up to 30% by weight – Davis explained.

He added that resulting 'drug load' is between 5 and ten times higher than that found in currently available patches and gels.

The adhesive is exclusively licensed for transdermal use from Bostik, a unit of chemicals firm Arkema.

UK and global plans

Medherant and its academic partners intend to launch the first product to incorporate the technology – an over-the-counter pain treatment – sometime in the next two years Davis said adding that the organisations plan to “seek approval outside UK​.”

He also stressed that the technology has wider application, explaining that: “We know that a lot of other APIs can be incorporated in our patches​” and confirmed that Medherant is interested in partnering with the pharmaceutical industry.

Related news

Show more

Related products

show more

Eastern & Western Manufacturing Solutions

Eastern & Western Manufacturing Solutions

Piramal Pharma Solutions | 15-Mar-2022 | Technical / White Paper

The best manufacturing site for a product can change throughout the life cycle. When bringing new drugs to market, biopharma companies may benefit from...

Spray Dried Powders for High Dose Drug Delivery

Spray Dried Powders for High Dose Drug Delivery

Catalent | 01-Feb-2022 | Product Presentation

This Catalent webinar will explore how spray dried particles provide an attractive, carrier-free option for highly dispersed delivery of API to deep lung...

Related suppliers

Follow us

Products

View more

Webinars